Desk
Care quality
Provider performance, patient outcomes, and accreditation — how care is delivered and where it slips.
11 studies on this desk
- Who runs the clinical trials: academia, not pharma, 2026
Of the 589,453 studies registered on ClinicalTrials.gov, 71.4% are run by academic and hospital sponsors and only 22.1% by industry — the registry of medical research is led by universities, not pharma. Yet industry runs 41.2% of phased drug-development trials, and 53.8% of all sponsors registered just one study.
2026-06-17 · 9 min - The 1% penalty: which hospitals lose Medicare pay for hospital-acquired conditions, FY2026
In CMS's FY2026 Hospital-Acquired Condition Reduction Program, 719 of 3,055 hospitals — the worst-performing quarter by total HAC score — lose 1% of every Medicare payment for the year. The cut is graded on a curve: most hospitals beat the national infection baseline, yet a fixed quartile is penalized regardless.
2026-06-17 · 9 min - Where clinical trials stop: the Phase 2 valley, 2026
Of the 373,998 clinical trials on ClinicalTrials.gov that have reached a final outcome, 51,959 — about 1 in 7 — ended in discontinuation rather than completion. Attrition is uneven: 23.0% of settled Phase 2 trials stop early, against 14.7% at Phase 1, the signature of the efficacy-stage valley where a candidate must first prove it works.
2026-06-16 · 9 min - How serious is the average FDA recall? About one in eleven is the most serious tier
Of 56,777 FDA drug and device recalls on file, 5,237 — 9.2%, about one in eleven — carry Class I, the agency's most serious tier, signaling a reasonable probability of serious injury or death. Devices drive 68.9% of recalls; 99.4% are voluntary, company-initiated withdrawals, not FDA-ordered.
2026-06-14 · 11 min - GLP-1 drugs now cost Medicare Part D $24.57 billion a year
GLP-1 drugs cost Medicare Part D $24.57 billion in 2024 — 10.8% of the entire program's drug spending on just 1.3% of its prescriptions. Ozempic alone, at $12.38 billion, is the second-costliest drug in Part D; Mounjaro and Trulicity push the class past $24 billion.
2026-06-12 · 11 min - HAC Reduction Program: 719 Hospitals Penalized in FY2026
719 hospitals — 23.9% of 3,012 eligible — were penalized under the CMS Hospital-Acquired Condition (HAC) Reduction Program in FY2026, losing 1% of every Medicare payment for a full fiscal year. Every penalized hospital is named from official CMS data with reproducible methodology and a state-by-state breakdown.
2026-06-06 · 10 min - How fast do nursing homes fix what surveyors cite? 28.5 days for the harmful ones
Across 415,849 corrected CMS nursing home health deficiencies, the mean time from survey to documented correction is 32 days — but the harm-level citations, Severity G and above, close faster, in 28.5 days. The more severe the finding, the quicker the fix. Texas and Illinois correct in about two weeks; Washington, D.C. takes nine.
2026-06-04 · 14 min - DaVita and Fresenius Control 74% of U.S. Dialysis: A Facility-Level Comparison
DaVita and Fresenius Medical Care together operate 73.7% of the 7,557 Medicare-certified dialysis facilities in the United States. Chain-owned centers average 2.92 CMS stars versus 2.27 for independents — independents are 3.7× more likely to receive a 1-star rating. State-level market concentration, chain rankings, and reproducible SQL from CMS Care Compare.
2026-06-04 · 12 min - 1,753 Four- and Five-Star Nursing Homes Had Severity-G or Worse Deficiencies
30% of four- and five-star CMS-rated nursing homes had at least one severity-G or worse deficiency in the three-year window: 668 five-star facilities and 1,085 four-star. Severity G means a CMS surveyor documented actual harm to a resident. Every facility named from federal data with reproducible SQL and sub-rating analysis.
2026-06-04 · 14 min - Nursing Home Ownership Networks: Chain Operators, REITs, and the 82% Data Gap
The 14,699 Medicare-certified nursing homes in the United States are nominally owned by thousands of entities, but effective control is concentrated in fewer than 50 documented chain operators and 4 healthcare REIT landlords. The CMS SNF All Owners dataset reveals the network — and the 82.40% top-10-chain data gap that makes full disclosure structurally impossible.
2026-06-03 · 14 min - Why 14% of skilled nursing facilities had a quality drop in Q1
Across 5,148 SNFs in Q1 2026, the composite quality score declined by an average of 0.06 points — but the decline was not evenly distributed. Facilities that changed ownership in the prior twelve months accounted for a disproportionate share of the slide.
2026-05-12 · 8 min
Other desks
All research →